Neurabin-II Inhibitors

Neurabin-II inhibitors encompass a diverse group of compounds that target various cellular pathways to indirectly modulate the function and localization of Neurabin-II, a key regulator of actin cytoskeleton dynamics. While direct inhibitors of Neurabin-II may not be well-established, these compounds influence pathways associated with Neurabin-II regulation. CK666 and CK869 are inhibitors of the Arp2/3 complex, critical for actin polymerization. By disrupting actin dynamics, these compounds indirectly impact Neurabin-II, which interacts with actin filaments. Similarly, Latrunculin A, Jasplakinolide, SMIFH2, Cytochalasin D, and Phalloidin affect actin polymerization or stability, influencing Neurabin-II localization through alterations in the actin cytoskeleton. Blebbistatin and ML-7 modulate myosin II activity, a protein that Neurabin-II interacts with. The inhibition of myosin II alters the dynamics of Neurabin-II interactions, affecting its cellular function. Additionally, Calyculin A inhibits protein phosphatases, leading to hyperphosphorylation of Neurabin-II and changes in its cellular localization and interactions. Nocodazole disrupts microtubules, inducing cellular responses that indirectly affect Neurabin-II function. This diverse set of compounds collectively highlights the intricate regulatory networks associated with Neurabin-II.